• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    WNS Announces Addition of Tim Main to Board of Directors

    5/18/21 4:15:00 PM ET
    $WNS
    $DGX
    $JBL
    $SHAC
    Business Services
    Consumer Discretionary
    Medical Specialities
    Health Care
    Get the next $WNS alert in real time by email

    WNS (Holdings) Limited (NYSE:WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the appointment of Timothy L. Main to the company's Board of Directors effective June 1, 2021. Tim has spent his entire career in a B2B services/outsourcing environment, including more than 25 years with Jabil, Inc. (NYSE:JBL), a leading provider of manufacturing services with a global operational footprint. At Jabil, Tim worked his way from a Production Control Manager position to eventually serve as President, Chief Executive Officer, and Chairman of the Board. During his 13-year tenure as Chief Executive Officer of Jabil, he led the company's transformation and growth to a $17+ billion, 100,000 employee organization through organic growth and strategic acquisitions. Tim is currently non-executive Chairman of the Board of Directors and a member of the Cyber Committee at Jabil. In addition, he serves on the Board of Quest Diagnostics (NYSE:DGX) as Chair of the Cybersecurity Committee and a member of the Audit & Finance and Governance committees, and on the Board of SCP & CO Healthcare Acquisition Co. (NASDAQ:SHAC), where he serves as a member of the Audit & Finance Committee.

    "Tim is a proven leader with a distinguished track record in international operations, corporate governance, vision and strategy, and technology-led growth," said Adrian T. Dillon, WNS's Chairman of the Board. "We are pleased to welcome Tim to the WNS Board of Directors, and believe that his experience guiding large organizations and developing talent will be a tremendous asset to the company."

    "The WNS team is delighted to add an experienced executive like Tim to our Board," said Keshav R. Murugesh, Chief Executive Officer of WNS. "His background in leading high-performing teams, driving both organic and inorganic revenue growth, and managing global operations will help WNS continue to generate exceptional value for all of our key stakeholders."

    About WNS

    WNS (Holdings) Limited (NYSE:WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 375 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer interaction services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of March 31, 2021, WNS had 43,997 professionals across 58 delivery centers worldwide including facilities in Australia, China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States. For more information, visit www.wns.com.

    Safe Harbor Provision

    This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006071/en/

    Get the next $WNS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WNS
    $DGX
    $JBL
    $SHAC

    CompanyDatePrice TargetRatingAnalyst
    Jabil Inc.
    $JBL
    6/18/2025Hold → Buy
    Argus
    Quest Diagnostics Incorporated
    $DGX
    4/2/2025$195.00Buy
    Redburn Atlantic
    Quest Diagnostics Incorporated
    $DGX
    3/4/2025$185.00Buy → Neutral
    Citigroup
    Quest Diagnostics Incorporated
    $DGX
    1/6/2025$169.00 → $174.00Market Perform → Outperform
    Leerink Partners
    Quest Diagnostics Incorporated
    $DGX
    12/17/2024$145.00 → $172.00Equal-Weight → Overweight
    Morgan Stanley
    Quest Diagnostics Incorporated
    $DGX
    12/10/2024$175.00 → $185.00Buy
    Jefferies
    Quest Diagnostics Incorporated
    $DGX
    10/23/2024$157.00 → $182.00Neutral → Outperform
    Robert W. Baird
    WNS (Holdings) Limited
    $WNS
    10/17/2024$64.00 → $53.00Buy → Hold
    TD Cowen
    More analyst ratings

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP Chintapalli Anil bought $1,115,226 worth of shares (20,000 units at $55.76), increasing direct ownership by 72% to 47,900 units (SEC Form 4)

      4 - WNS (HOLDINGS) LTD (0001356570) (Issuer)

      6/2/25 4:41:04 PM ET
      $WNS
      Business Services
      Consumer Discretionary

    $WNS
    $DGX
    $JBL
    $SHAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jabil upgraded by Argus

      Argus upgraded Jabil from Hold to Buy

      6/18/25 8:08:30 AM ET
      $JBL
      Electrical Products
      Technology
    • Redburn Atlantic initiated coverage on Quest Diagnostics with a new price target

      Redburn Atlantic initiated coverage of Quest Diagnostics with a rating of Buy and set a new price target of $195.00

      4/2/25 8:51:11 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics downgraded by Citigroup with a new price target

      Citigroup downgraded Quest Diagnostics from Buy to Neutral and set a new price target of $185.00

      3/4/25 7:20:57 AM ET
      $DGX
      Medical Specialities
      Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    SEC Filings

    See more
    • Jabil Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - JABIL INC (0000898293) (Filer)

      6/24/25 4:05:20 PM ET
      $JBL
      Electrical Products
      Technology
    • SEC Form 11-K filed by Quest Diagnostics Incorporated

      11-K - QUEST DIAGNOSTICS INC (0001022079) (Filer)

      6/20/25 4:20:51 PM ET
      $DGX
      Medical Specialities
      Health Care
    • SEC Form S-3ASR filed by Quest Diagnostics Incorporated

      S-3ASR - QUEST DIAGNOSTICS INC (0001022079) (Filer)

      6/20/25 4:08:24 PM ET
      $DGX
      Medical Specialities
      Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Quest Diagnostics Releases 2024 Corporate Responsibility Report

      SECAUCUS, N.J., June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report. The theme of the report, Care Starts Here, reflects the pivotal role Quest plays in an individual's healthcare, providing insights from laboratory diagnostics to drive well-informed decisions. The report details Quest's accomplishments in 2024 across the company's four strategic pillars of corporate responsibility: health access, employee and community engagement, governance and ethics, and environme

      6/25/25 9:07:00 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

      SECAUCUS, N.J., June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial results on Tuesday, July 22, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.Q

      6/23/25 10:52:00 AM ET
      $DGX
      Medical Specialities
      Health Care
    • Jabil Posts Third Quarter Results

      Raises Fiscal 2025 Outlook Today, Jabil Inc. (NYSE:JBL), reported preliminary, unaudited financial results for its third quarter of fiscal year 2025. Third Quarter of Fiscal Year 2025 Highlights: Net revenue: $7.8 billion U.S. GAAP operating income: $403 million U.S. GAAP diluted earnings per share: $2.03 Core operating income (Non-GAAP): $420 million Core diluted earnings per share (Non-GAAP): $2.55 "We delivered a strong third quarter, outperforming expectations across key end-markets such as cloud, data center infrastructure, and capital equipment," said CEO Mike Dastoor. "Our Intelligent Infrastructure segment remains a critical growth engine, benefiting from accel

      6/17/25 7:45:00 AM ET
      $JBL
      Electrical Products
      Technology